Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Crystal forms of a HCV protease inhibitor

Crystal forms of a HCV protease inhibitor

US Patent 9242917 · Granted Jan 26, 2016

Estimated economic value: $42,047,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-p2024
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for t2024
Low molecular weight cationic lipids for oligonucleotide delivery2024
Synthetic pathway to belzutifan and crystalline phases of synthetic intermediate2023
Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them2023
Low molecular weight cationic lipids for oligonucleotide delivery2022
Crystalline form of a BACE inhibitor, compositions, and use2022
Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) pipera2022
Substituted quinolinylcyclohexylpropanamide compounds and improved methods for t2022
Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazi2020
Low molecular weight cationic lipids for oligonucleotide delivery2020
Substituted phosphoramidate compounds and uses thereof2020